Blood test could predict radiation dry mouth before it starts
NCT ID NCT07170358
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is looking for early biological markers in the blood that could predict dry mouth caused by radiation therapy in head and neck cancer patients. Researchers will collect blood samples from 126 patients before and after treatment and use advanced techniques to find these markers. The goal is to identify dry mouth early so doctors can intervene sooner and improve patients' quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test to predict dry mouth before symptoms start, allowing early treatment and better quality of life.
What could go wrong
This is an early-stage observational study, not a treatment trial. The biomarkers found may not be accurate enough for routine use, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for XEROSTOMIA DUE TO RADIOTHERAPY (DISORDER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Jinling Hospital, Medical School of Nanjing University
RECRUITINGNanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiangsu Cancer Hospital
RECRUITINGNanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Nanjing Medical University
NOT_YET_RECRUITINGNanjing, Jiangsu, 210018, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••